CN112063529A - Red card skeleton powder and preparation method thereof - Google Patents
Red card skeleton powder and preparation method thereof Download PDFInfo
- Publication number
- CN112063529A CN112063529A CN202010813481.3A CN202010813481A CN112063529A CN 112063529 A CN112063529 A CN 112063529A CN 202010813481 A CN202010813481 A CN 202010813481A CN 112063529 A CN112063529 A CN 112063529A
- Authority
- CN
- China
- Prior art keywords
- powder
- bacterial
- culture medium
- liquid
- red card
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 230000001580 bacterial effect Effects 0.000 claims abstract description 90
- 239000001963 growth medium Substances 0.000 claims abstract description 53
- 238000009630 liquid culture Methods 0.000 claims abstract description 44
- 239000000725 suspension Substances 0.000 claims abstract description 40
- 239000007788 liquid Substances 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 241000187654 Nocardia Species 0.000 claims abstract description 20
- 238000012258 culturing Methods 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 238000000227 grinding Methods 0.000 claims abstract description 8
- 238000010790 dilution Methods 0.000 claims abstract description 7
- 239000012895 dilution Substances 0.000 claims abstract description 7
- 239000006228 supernatant Substances 0.000 claims abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 29
- 239000008103 glucose Substances 0.000 claims description 29
- 229940041514 candida albicans extract Drugs 0.000 claims description 25
- 239000012138 yeast extract Substances 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- 238000011081 inoculation Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 239000002609 medium Substances 0.000 claims description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 108010039939 Cell Wall Skeleton Proteins 0.000 claims description 7
- 210000004520 cell wall skeleton Anatomy 0.000 claims description 7
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 210000004907 gland Anatomy 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 238000001994 activation Methods 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 25
- 210000002421 cell wall Anatomy 0.000 abstract description 7
- 239000003513 alkali Substances 0.000 abstract description 6
- 239000002253 acid Substances 0.000 abstract description 3
- 239000001913 cellulose Substances 0.000 abstract description 3
- 229920002678 cellulose Polymers 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 150000007513 acids Chemical class 0.000 abstract description 2
- 239000002585 base Substances 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 57
- 241000894006 Bacteria Species 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 230000012010 growth Effects 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 241001052560 Thallis Species 0.000 description 9
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 9
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 9
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 9
- 238000005303 weighing Methods 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 229920002749 Bacterial cellulose Polymers 0.000 description 5
- 239000005016 bacterial cellulose Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 238000007865 diluting Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000004880 explosion Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229910017053 inorganic salt Inorganic materials 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000000527 sonication Methods 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000008104 plant cellulose Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009967 tasteless effect Effects 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- SYDPDPVAWMKXAO-UHFFFAOYSA-N C1=CC=CC=2CC3=CC=CC=C3C(C12)=O.C(C)(=O)OCC Chemical compound C1=CC=CC=2CC3=CC=CC=C3C(C12)=O.C(C)(=O)OCC SYDPDPVAWMKXAO-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
- C12N1/066—Lysis of microorganisms by physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a red card skeleton powder and a preparation method thereof, belonging to the technical field of cellulose. The preparation method comprises the following steps: step one, inoculating activated Nocardia in a liquid culture medium, and culturing to obtain a bacterial liquid; step two, taking bacterial liquid, shaking up, centrifuging, discarding supernatant, adding distilled water for dilution, and mixing uniformly to obtain bacterial suspension; and thirdly, breaking the walls of the bacterial suspension by alkali liquor or ultrasonic waves, extracting cell wall frameworks, drying and grinding to obtain the red cardskeleton powder. The powder is white or quasi-white powder, and has no odor and odor; insoluble in water, dilute acids, dilute bases and most organic solvents; high purity, no impurity and high affinity. The gel additive can be added as an auxiliary material to obviously enhance the strength and toughness of the gel, improve the internal structural space of the gel, increase the drug carrying amount of the gel per unit mass, and achieve the effect of slow release.
Description
Technical Field
The invention belongs to the technical field of cellulose, and particularly relates to a red card skeleton powder and a preparation method thereof.
Background
Plant cellulose (cellulose) is a macromolecular polysaccharide composed of glucose and is the main component of plant cell walls. Bacterial Cellulose (BC for short) has the characteristics of high purity, high water retention, high tensile strength, good biocompatibility and the like compared with plant Cellulose, and therefore, is widely applied to many fields of biomedicine, food, cosmetics, textile industry, membrane filters and the like.
The existing bacterial cellulose appears in a gel form, has limited functions and effects and is not convenient for long-term storage; meanwhile, the powder is large in size and inconvenient to transport and carry, and the application of the powder prepared from the powder can be widened. However, the bacterial cellulose has a hyperfine three-dimensional network structure, the intermolecular force is strong, and the bacterial cellulose is difficult to be prepared into powder, which brings difficulty to processing and production. At present, bacterial cellulose powder can be prepared by using various drying modes such as spray drying and the like, but the prepared powder has nonuniform granularity, a plurality of excellent characteristics are lost, the cost is too high, and the method is not suitable for industrial production.
Disclosure of Invention
In view of the above, in order to solve the technical problems in the prior art, the invention provides a red cardskeleton powder and a preparation method thereof.
The technical scheme adopted by the invention for solving the technical problems is as follows.
The invention firstly provides a preparation method of a red card framework powder, which comprises the following steps:
step one, inoculating activated Nocardia in a sterilized liquid culture medium, wherein the inoculation amount of 35-75mL of the liquid culture medium is 0.25-0.1mL, and performing shake culture at 24-30 ℃ for more than 24 hours to obtain a bacterial liquid;
the liquid culture medium contains 1 wt% of carbon source and 1 wt% of nitrogen source, the carbon source is glucose, sucrose, starch or mannitol, the nitrogen source is yeast extract, protein gland, urea or a sulfuric acid string, and the pH is 6-8;
step two, taking bacterial liquid, shaking up, centrifuging, discarding supernatant, adding distilled water for dilution, and mixing uniformly to obtain bacterial suspension with the mass concentration of 1.5 g/L;
step three, placing the bacterial suspension into 5-5.5% KOH solution, and carrying out water bath at 100 ℃ for 10-50 min;
or, performing ultrasonic wall breaking on the bacterial suspension, wherein the wall breaking conditions are ultrasonic time 1-15s, interval time 5-15s, cycle number 40-90 times and power 100-;
and step four, extracting the cell wall skeleton, drying and grinding to obtain the red cardskeleton powder.
Preferably, in the first step, the activation process of nocardia is as follows: inoculating Nocardia genus into solid culture medium by streaking, and culturing at 28 deg.C for two days;
the solid medium contains 1 wt% of glucose, 1 wt% of yeast extract and 2 wt% of agar, and has a pH of 7.2.
Preferably, in the first step, the sterilization temperature is 115-118 ℃, and the sterilization time is 20 min.
Preferably, in the first step, the rotation speed of the shaking table is 160-.
Preferably, in the first step, the carbon source of the liquid culture medium is glucose powder, and the nitrogen source is yeast powder; the pH of the liquid culture medium is 7-8; more preferably 7.2 to 7.4.
Preferably, in the first step, the temperature for culturing is 26 ℃.
Preferably, in the first step, the inoculation amount of the 50mL liquid culture medium is 0.75 mL.
Preferably, in the second step, the rotation speed of the centrifugation is 4000r/min, and the time is 5 min.
Preferably, in the third step, the bacterial suspension is placed in a 5% KOH solution, and is subjected to water bath at 100 ℃ for 40 min;
in the third step, the wall breaking conditions are ultrasonic time 15s, interval time 15s, cycle number 40 times and power 500W.
The invention also provides the red card skeleton powder prepared from the red card skeleton powder.
Compared with the prior art, the invention has the beneficial effects that:
the red card framework powder is white or white-like powder, and is odorless and tasteless; insoluble in water, dilute acids, dilute bases and most organic solvents; high purity, no impurity and high affinity. The gel can be added as an auxiliary material to obviously enhance the strength and toughness of the gel, improve the internal structural space of the gel, increase the drug carrying amount of the gel per unit mass, and achieve the effect of slow release, namely, the content of other drugs can be improved and the release degree of active ingredients is increased. And is expected to be applied to the fields of human body dressings, nursing and cleaning products, tissue engineering scaffolds and the like.
Drawings
In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings needed to be used in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art that other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 shows the cell counts of bacterial suspensions at different concentrations in example 7 of the present invention;
FIG. 2 is a graph showing the effect of different total disruption times on the bacterial disruption rate in example 8 of the present invention;
FIG. 3 is a graph showing the effect of time per sonication on the degree of disruption in example 9 of the present invention;
FIG. 4 is a graph showing the effect of ultrasonic output power on the crushing ratio in example 10 of the present invention;
FIG. 5 is a graph showing the effect of KOH concentration on bacterial disruption rate in example 12 of the present invention;
FIG. 6 is a graph showing the effect of treatment time on bacterial disruption rate in example 13 of the present invention.
Detailed Description
For a further understanding of the invention, preferred embodiments of the invention are described below in conjunction with the detailed description, but it is to be understood that the description is intended to further illustrate the features and advantages of the invention and not to limit the claims to the invention.
The preparation method of the red card framework powder comprises the following steps:
step one, inoculating activated Nocardia in a sterilized liquid culture medium, wherein the inoculation amount of 35-75mL of the liquid culture medium is 0.25-0.1mL, and performing shake culture at 24-30 ℃ for more than 24 hours to obtain a bacterial liquid;
the liquid culture medium contains 1 wt% of carbon source and 1 wt% of nitrogen source, the carbon source is glucose, sucrose, starch or mannitol, the nitrogen source is yeast extract, protein gland, urea or a sulfuric acid string, and the pH is 6-8;
step two, taking bacterial liquid, shaking up, centrifuging, discarding supernatant, adding distilled water for dilution, and mixing uniformly to obtain bacterial suspension with the mass concentration of 1.5 g/L;
step three, placing the bacterial suspension into 5-5.5% KOH solution, and carrying out water bath at 100 ℃ for 10-50 min;
or, performing ultrasonic wall breaking on the bacterial suspension, wherein the wall breaking conditions are ultrasonic time 1-15s, interval time 5-15s, cycle number 40-90 times and power 100-;
and step four, extracting the cell wall skeleton, drying and grinding to obtain the red cardskeleton powder.
In the above technical scheme, in the step one, the activation process of nocardia is the prior art, and usually comprises: inoculating Nocardia genus into solid culture medium by streaking, and culturing at 28 deg.C for two days; the solid medium contained 1 wt% glucose, 1 wt% yeast extract and 2 wt% agar, and had a pH of 7.2. The Nocardia used in the invention is the prior art and is provided by the center for storing strains of the institute of Life sciences of the university of Fujian Master.
In the above technical scheme, in the first step, the sterilization temperature is 115-118 ℃, and the sterilization time is 20 min.
In the above technical solution, in the step one, the rotation speed of the shaking table is 160-.
According to the technical scheme, in the first step, a carbon source of a liquid culture medium is glucose powder, and a nitrogen source is yeast powder; the pH of the liquid culture medium is 7-8; more preferably 7.2 to 7.4.
In the technical scheme, in the step one, the culture temperature is 26 ℃.
In the above technical scheme, in the first step, the inoculation amount of 50mL of liquid culture medium is 0.75 mL.
In the technical scheme, in the second step, the rotating speed of the centrifugation is 4000r/min, and the time is 5 min.
In the technical scheme, in the third step, when 5% KOH suspension bacteria liquid is used, a good wall-breaking effect can be obtained after 40min of water bath at 100 ℃, and the wall-breaking rate can basically reach more than 90%; therefore, the bacterial suspension is preferably placed in a 5% KOH solution and subjected to water bath at 100 ℃ for 40 min.
According to the technical scheme, in the third step, the cell is crushed by a short-time multiple crushing mode and the bacterial suspension with the mass concentration of 1.5 g/L. The ultrasonic treatment time is more suitable at 15s, and the upper limit of the wall breaking rate can reach 84.36 percent within a 95 percent confidence interval; 40 cycles are more suitable working cycles, and the upper limit of the wall breaking rate of the device can reach 75.67 percent within a 95 percent confidence interval; 500W is more suitable ultrasonic power, and the upper limit of the wall breaking rate of the ultrasonic wave breaking device can reach 70.81% within a 95% confidence interval. Therefore, the ultrasonic wave time 15s, the interval time 15s, the number of operation cycles 40, and the ultrasonic wave power 500W are preferable. The probe of the ultrasonic wave is immersed at a liquid level of about 15 mm.
The terms used in the present invention generally have meanings commonly understood by those of ordinary skill in the art, unless otherwise specified.
In order to make the technical solutions of the present invention better understood by those skilled in the art, the present invention will be further described in detail with reference to the following embodiments and the accompanying drawings.
In the following examples, various procedures and methods not described in detail are conventional methods well known in the art. Materials, reagents, devices, instruments, apparatuses and the like used in the following examples are commercially available unless otherwise specified.
Example 1
Step one, inoculating activated Nocardia (cultured for 2 days) into a sterilized liquid culture medium (sterilized at 115 ℃ for 20min), wherein the inoculation amount of 50mL of the liquid culture medium is 0.75mL, and culturing for 24h in a shaking table (240r/min) at 28 ℃ to obtain a bacterial liquid;
the liquid culture medium is: preparing liquid culture media according to the proportion that a carbon source and a nitrogen source are 0.5g (1 wt%), and combining four carbon sources of glucose, sucrose, starch and mannitol and four nitrogen sources of yeast extract, protein gland, urea and sulfuric acid string two by two to prepare 16 different liquid culture media; adjusting the pH to 7.2;
step two, taking bacterial liquid, shaking up, centrifuging for 5min at 4000r/min, discarding supernatant, adding distilled water for dilution, and uniformly mixing by using a magnetic stirrer to obtain bacterial suspension with the mass concentration of 1.5 g/L;
step three, carrying out ultrasonic wall breaking on the bacterial suspension, wherein the wall breaking conditions are ultrasonic time 15s, interval time 15s, cycle number 40 times and power 500W;
and step four, extracting the cell wall skeleton, drying and grinding to obtain the red cardskeleton powder.
The wet weight of the bacterial cells of the bacterial liquid obtained in the first step of example 1 was weighed. The wet weight test method of the thallus comprises the following steps: centrifuging the bacterial liquid for 10min at 5000r/min by using a centrifugal machine, discarding supernatant, weighing to obtain the wet weight of the thallus, and generally taking an average value by adopting three times of measurement. The test results are shown in table 1.
TABLE 1 Wet weight of bacterial cells of the bacterial suspension obtained in the first step of example 1
As can be seen from Table 1, different media are suitable for the cultivation of the bacteria of the invention; among them, the combination of glucose/yeast extract gave the greatest bacterial weight, indicating that the combination of glucose/yeast extract is most suitable for the growth of the bacterial cells.
Example 2
Step one, inoculating activated Nocardia (cultured for 2 days) into a sterilized liquid culture medium (sterilized at 115 ℃ for 20min), wherein the inoculation amount of 50mL of the liquid culture medium is 0.75mL, and culturing for 24h in a shaking table (240r/min) at 28 ℃ to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract culture medium (glucose 1 wt%, yeast extract 1 wt%), pH 5, 6, 7, 7.2, 8;
step two to step four are the same as in example 1.
The wet weight of the bacterial cells of the bacterial liquid obtained in the first step of example 2 was weighed. The wet weight of the cells was measured in the same manner as in example 1. The test results are shown in table 2.
TABLE 2 wet weight of bacterial cells of the bacterial suspension obtained in the first step of example 2
As is clear from Table 2, the pH of 5 is due to the fact that the cells hardly grow and the medium should be peracid. The increase of the pH value causes the increase of the cell weight, the cell weight reaches the maximum when the pH value is 7, and the cell weight slightly decreases when the pH value is 8, which is the reason that the culture medium is alkaline. The pH value is between 7 and 8, which is most suitable for the growth of the thallus.
Example 3
Step one, inoculating activated Nocardia (cultured for 2 days) into a sterilized liquid culture medium (sterilized for 20min at 115 ℃), wherein the inoculation amount of 50mL of the liquid culture medium is 0.75mL, and culturing for 24h at 28 ℃ to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract medium (glucose 1 wt%, yeast extract 1 wt%), pH 7.2;
the cultivation respectively comprises 160r/min of a shaking table, 200r/min of the shaking table, 240r/min of the shaking table, 280r/min of the shaking table and 320r/min of the shaking table, complete standing, 6h of shaking table (240r/min) cultivation, 6h of standing cultivation (circulation 24h) in a constant temperature incubator, 4h of shaking table (240r/min) cultivation and 4h of standing cultivation (circulation 24h) in the constant temperature incubator;
step two to step four are the same as in example 1.
The wet weight of the bacterial cells of the bacterial liquid obtained in the first step of example 3 was weighed. The wet weight of the cells was measured in the same manner as in example 1. The test results are shown in table 3.
TABLE 3 wet weight of bacterial cells of the bacterial suspension obtained in the first step of example 3
As can be seen from Table 3, the growth effect of the cells was poor and the yield was very low during the static culture; in the case of the alternate culture, the yield of the cells was increased, and the effect of the culture at the 6-hour interval was inferior to that at the 4-hour interval, i.e., the shorter the interval, the better the culture effect. When the continuous shaking table culture is carried out, the yield of the thalli is greatly improved compared with that of the thalli which is kept still and is cultured at intervals, and along with the improvement of the rotating speed of the shaking table, the thalli are greatly increased, but the increase is not obvious. When the rotating speed of the shaking table is 320r/min, the bacterial weight reaches the maximum.
Example 4
Step one, inoculating activated Nocardia (cultured for 2 days) into a sterilized liquid culture medium (sterilized at 115 ℃ for 20min), wherein the inoculation amount of 50mL of the liquid culture medium is 0.75mL, and performing shake culture (240r/min) at 24 ℃, 26 ℃, 28 ℃ and 30 ℃ for 24h respectively to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract medium (glucose 1 wt%, yeast extract 1 wt%), pH 7.2.
Step two to step four are the same as in example 1.
The wet weight of the bacterial cells of the bacterial liquid obtained in the first step of example 4 was weighed. The wet weight of the cells was measured in the same manner as in example 1. The test results are shown in table 4.
TABLE 4 wet weight of bacterial cells of the bacterial suspension obtained in the first step of example 4
As can be seen from Table 4, the productivity of the cells reached the maximum at the culture temperature of 26 ℃ indicating that it is most suitable for the growth of the cells at this temperature; when the temperature is lower than 26 ℃, the yield of the bacteria is in direct proportion to the temperature and is increased along with the increase of the temperature; when the temperature is higher than 26 ℃, the yield of the bacteria is inversely proportional to the temperature, and decreases with the increase of the temperature.
Example 5
Step one, respectively inoculating 0.75mL of activated Nocardia (cultured for 2 days) into 30mL, 45mL, 50mL, 60mL and 75mL of liquid culture medium after sterilization (sterilized at 115 ℃ for 20min), and performing shake culture (240r/min) at 28 ℃ for 24h to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract medium (glucose 1 wt%, yeast extract 1 wt%), pH 7.2.
Step two to step four are the same as in example 1.
The wet weight of the bacterial cells of the bacterial liquid obtained in the first step of example 5 was weighed. The wet weight of the cells was measured in the same manner as in example 1. The test results are shown in table 5.
TABLE 5 wet weight of bacterial cells of the bacterial suspension obtained in the first step of example 5
As can be seen from Table 5, when the volume of the culture medium is between 30 and 45mL, the cell yield is slightly reduced with the decrease of the dissolved oxygen amount, and the cell growth effect is proportional to the dissolved oxygen amount. When the volume of the culture solution is between 45 and 75mL, the yield of the thalli is gradually increased along with the reduction of the dissolved oxygen, and the growth effect of the thalli is inversely proportional to the dissolved oxygen. The reason is probably that when the volume of the culture solution is between 45 and 75mL, the factors of the nutrients in the culture medium are dominant, and the influence of the nutrients on the thalli is greater than that of the dissolved oxygen, so that the thalli can obtain more nutrients along with the increase of the volume of the culture solution, and the growth effect is better. On the other hand, when the volume of the culture medium is 45mL or less, the amount of dissolved oxygen in the cells is larger than that of the nutrients, and the cell yield decreases as the amount of dissolved oxygen decreases.
Example 6
Step one, respectively inoculating 0.25mL (0.5%), 0.5mL (1%), 0.75mL (1.5%) and 0.1mL (2%) of activated Nocardia (cultured for 2 days) into 75mL of liquid culture medium after sterilization (sterilized at 115 ℃ for 20min), and performing shaking culture at 28 ℃ for 24h (240r/min) to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract medium (glucose 1 wt%, yeast extract 1 wt%), pH 7.2;
step two to step four are the same as in example 1.
The wet weight of the bacterial cells of the bacterial liquid obtained in the first step of example 6 was weighed. The wet weight of the cells was measured in the same manner as in example 1. The test results are shown in table 6.
TABLE 6 wet cell weight of the bacterial suspension obtained in the first step of example 6
As can be seen from Table 6, the maximum yield of the obtained bacteria was obtained when the inoculum size was 0.50mL (1%); when the inoculation amount is less than 0.50mL, the yield of the bacteria and the inoculation amount are in positive correlation and increase along with the increase of the inoculation amount; when the inoculation amount is more than 0.50mL, the yield of the bacteria is inversely proportional to the inoculation amount, and the growth condition of the bacteria is reduced along with the increase of the inoculation amount. The reason is probably that the culture solution has a certain volume, the nutrient in the culture medium is limited, the nutrient is insufficient due to the overlarge inoculation amount, and the growth of thalli is inhibited, so that the yield of the thalli is reduced. When the volume of the culture solution is constant, the inoculum size has a maximum value, about 0.5mL, and when the inoculum size is less than 0.5mL, the obtained bacterial weight increases with the increase of the inoculum size, and when the inoculum size is more than 0.5mL, the growth condition of the thallus is reduced, which is supposed to be the reason of insufficient nutrients.
Example 7
Step one, inoculating activated Nocardia (cultured for 2 days) into a sterilized liquid culture medium (sterilized at 115 ℃ for 20min), wherein the inoculation amount of 50mL of the liquid culture medium is 0.75mL, and culturing for 24h, 48h, 72h, 96h, 168h and 216h in a shaking table (240r/min) at 28 ℃ to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract medium (glucose 1 wt%, yeast extract 1 wt%), pH 7.2;
step two, taking bacterial liquid, shaking up, centrifugally separating for 5min (the rotating speed is 4000r/min), discarding supernate, adding distilled water for diluting, and uniformly mixing by using a magnetic stirrer to obtain bacterial suspension with the mass concentration of 1.5 g/L;
and step three, performing ultrasonic wall breaking on the bacterial suspension, wherein the wall breaking conditions are ultrasonic time 15s, interval time 15s, cycle number 40 times and power 500W.
And step four, extracting the cell wall skeleton, drying and grinding to obtain the red cardskeleton powder.
The cell number of the bacterial suspension after the cell wall breaking in the third step of example 7 is detected, and the cell number in the bacterial suspension after the cell wall breaking is obtained by counting with a blood counting chamber (the cell number is the average value of the cell number of the bacterial suspension in the cells in the blood counting chamber, and part of data is obtained by converting the cell number in each cell by the dilution factor). The results are shown in FIG. 1.
As can be seen from FIG. 1, as the number of cells increased, cell breakage increased first and then decreased. At high bacterial suspension concentrations, this results in increased viscosity which is detrimental to vacuole formation, expansion and explosion, while at low bacterial concentrations it reduces the chance of contact with cells during vacuole expansion and explosion.
Example 8
Step one, inoculating activated Nocardia (cultured for 2 days) into a sterilized liquid culture medium (sterilized at 115 ℃ for 20min), wherein the inoculation amount of 50mL of the liquid culture medium is 0.75mL, and culturing for 24h in a shaking table (240r/min) at 28 ℃ to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract medium (glucose 1 wt%, yeast extract 1 wt%), pH 7.2;
step two, taking bacterial liquid, shaking up, centrifugally separating for 5min (the rotating speed is 4000r/min), discarding supernate, adding distilled water for diluting, and uniformly mixing by using a magnetic stirrer to obtain bacterial suspension with the mass concentration of 1.5 g/L;
step three, performing ultrasonic wall breaking on the bacterial suspension, wherein the wall breaking conditions are as follows: the working power of the ultrasonic crusher is 300W, the interval is 15s after crushing for 12s every time, 10, 20, 30, 40, 50 and 60 cycles are respectively set, and crushing is carried out for three times, namely the whole crushing time is respectively 6min, 12min, 18min, 24min, 30min and 36 min.
The bacteria were counted on a hemacytometer at 87 × 10 n/ml (n ═ 6) before disruption. The impact of the whole crushing time on the crushing effect was examined and the results are shown in fig. 2. As can be seen from FIG. 2, the bacterial disruption rate is obviously increased along with the extension of the whole disruption time, which shows that the extension of the whole disruption time can increase the radiation of ultrasonic waves to the bacteria, thereby being beneficial to the disruption of the bacteria. However, since the ultrasonic disruption method is a relatively vigorous cell disruption method, the structure and properties of the protein are easily destroyed after a long time. So the whole crushing time does not exceed 30 min.
And step four, extracting the cell wall skeleton, drying and grinding to obtain the red cardskeleton powder.
Example 9
The first to fourth steps are the same as example 8, and the wall breaking conditions are as follows: the working power of the ultrasonic crusher is 300W, the crushing time is respectively set to 1s, 2s, 3s, 4s, 5s, 10s, 12s and 15s, the interval is 15s, 90 cycles are set, and the crushing is carried out for 1 time.
The bacteria were counted on a hemacytometer at 81 × 10 n/ml (n ═ 6) before disruption. The effect of each ultrasonication time on the crushing effect was examined, and the results are shown in FIG. 3. As can be seen from FIG. 3, the cell disruption rate increased and then decreased with the increase of the time for each sonication at intervals of 2s, and the disruption rate decreased significantly with each sonication less than 2s or more than 2 s. The process that the ultrasonic wave breaks the cells through the cavitation effect is actually the process that cavitation bubbles are formed, vibrated, expanded, compressed and collapsed to be closed, the process needs a very short time to be completed, and the short-time and multiple working modes can ensure that the cavitation bubbles generated by the ultrasonic wave have enough time and more chances to complete the processes of expansion and explosion, thereby being beneficial to cell breaking.
Example 10
The first to fourth steps are the same as example 8, and the wall breaking conditions are as follows: the working power of the ultrasonic crusher is respectively 100W, 200W, 300W, 400W, 500W and 600W, the time is respectively set to be 5s after 2s, 60 cycles are set, and crushing is carried out for 1 time.
The bacteria were counted on a hemocytometer at 102X 10 n/ml before disruption. The influence of the output power on the crushing rate was examined. The structure is shown in fig. 4, and it can be seen from the figure that the output power of the ultrasonic wave has a great influence on the bacterial breakage rate, and the bacterial breakage rate increases with the increase of the output power of the ultrasonic wave, because the increase of the output power causes more cavities to be formed in the liquid, and further more cavitation bubbles are generated, so that the breakage effect is enhanced. The degree of increase in the crushing rate is not significant after the power is increased to 500W, and the output power of 500-600W is considered to be suitable in view of the requirements of the ultrasonic crusher per se.
Example 11
The first to fourth steps were the same as in example 8, the wall breaking conditions are shown in table 7, and the test results are shown in table 8.
Table 7 wall breaking conditions of example 11
TABLE 8 test results of example 11
As can be seen from table 8: the ultrasonic treatment time is more suitable at 15s, and the upper limit of the wall breaking rate can reach 84.36 percent within a 95 percent confidence interval; 40 cycles are more suitable working cycles, and the upper limit of the wall breaking rate of the device can reach 75.67 percent within a 95 percent confidence interval; 500W is more suitable ultrasonic power, and the upper limit of the wall breaking rate of the ultrasonic wave breaking device can reach 70.81% within a 95% confidence interval. Therefore, the ultrasonic wave time is preferably 15s, the time interval is preferably 15s, the cycle number is preferably 40 times, and the power is preferably 300W.
Example 12
Step one, step two and step four are the same as embodiment 8, and step three is: sucking 1ml of the bacterial suspension into a test tube, respectively adding 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% KOH1mL by mass percent, and carrying out water bath treatment at 100 ℃ for 30 min.
The alkali can dissolve the soluble polysaccharide layer in the cell wall and part of lipid, so that the permeability of the cell wall is increased, and the intracellular substances are easy to separate out. The bacteria of example 12 were tested for breakage rate, which is the average of the number of cells in each cell of the hemacytometer, and the results are shown in FIG. 5. As can be seen from FIG. 5, on the basis of the treatment time of 30min at the water bath temperature of 100 ℃, the wall-breaking rate of the cells is obviously increased along with the increase of the mass fraction of KOH, when the mass fraction of KOH reaches about 5%, the wall-breaking rate reaches the maximum, and when the mass fraction of KOH exceeds 90% and is continuously increased along with the mass fraction of KOH, the wall-breaking rate value fluctuates up and down at 90%, and is basically maintained at about 90%, and the wall-breaking rate tends to be stable. The possible reason is that the alkaline hydrolysis reaction gradually reaches equilibrium as the alkali concentration increases, and the cell wall-breaking rate gradually reaches equilibrium as the alkali concentration increases after the reaction reaches equilibrium. Therefore, in actual operation, better wall breaking effect can be obtained by selecting KOH with the mass fraction of 5% to carry out cell wall breaking.
Example 13
Step one, step two and step four are the same as embodiment 8, and step three is: sucking the bacterial suspension ImL into a test tube, adding 5.0% KOH solution ImL, treating in 100 deg.C water bath for 10min, 20min, 30min, 40min, 50min, and performing cell disruption.
The results of examining the breakage of the bacteria of example 13 and the effect of the treatment time on the alkali wall-breaking effect are shown in FIG. 6. As can be seen from fig. 6, on the basis that the mass fraction of KOH is 5% and the water bath temperature is 100 ℃, the wall-breaking rate is significantly improved along with the extension of the treatment time, and when the treatment time reaches 40min, the wall-breaking rate can reach more than 90%, the treatment time is continuously improved, and the increase of the wall-breaking rate is small. Therefore, 40min is preferably used as the treatment time for alkali wall breaking.
Example 14
Step one, inoculating activated Nocardia (cultured for 2 days) into a sterilized liquid culture medium (sterilized at 115 ℃ for 20min), wherein the inoculation amount of 50mL of the liquid culture medium is 0.75mL, and culturing for 24h in a shaking table (240r/min) at 28 ℃ to obtain a bacterial liquid;
the liquid culture medium is: glucose/yeast extract medium (glucose 1 wt%, yeast extract 1 wt%), pH 7.2;
step two, taking bacterial liquid, shaking up, centrifuging for 5min at 4000r/min, discarding supernatant, adding distilled water for dilution, and uniformly mixing by using a magnetic stirrer to obtain bacterial suspension with the mass concentration of 1.5 g/L;
step three, placing the bacterial suspension in a 5% KOH solution, and carrying out water bath at 100 ℃ for 40 min;
or, performing ultrasonic wall breaking on the bacterial suspension, wherein the wall breaking conditions are ultrasonic time 15s, interval time 15s, cycle number 40 times and power 500W.
And step four, extracting the cell wall skeleton, drying and grinding to obtain the red cardskeleton powder.
The wet weight of the bacterial cells of the bacterial suspension obtained in the first step of example 14 was weighed. The wet weight of the cells was measured in the same manner as in example 1. The test results are shown in table 9.
Comparative example 1
To the liquid medium of example 14, 0.025g of MgSO was added respectively4、KH2PO4、NaCl、CaCl2Otherwise, the same as example 14.
Weighing wet bacteria of the bacteria liquid obtained in the step one of the comparative example 1. The wet weight of the cells was measured in the same manner as in example 1. The test results are shown in table 9.
TABLE 9 wet cell weights of the bacterial suspension obtained in example 14 and the first step of comparative example 1
As is clear from Table 9, the weight of the cells was less than that of example 14 when 0.025g of the inorganic salt was added to the medium, indicating that the addition of the inorganic salt inhibited the growth of the cells as a whole at this concentration. Among them, the inhibition effect of Ca ions is most remarkable, and the inhibition effect of Na ions is small. The inhibition of the growth of the cells may be caused by the collision between the added inorganic salt ions and the ions present in the original medium.
The red card skeleton powder obtained in example 14 was examined.
1.1 the red card skeleton powder is white or white-like powder observed, has no visible impurities and foreign matters, and is tasteless.
1.2 testing the pH value of the red card skeleton powder to be 5.0-7.5 by an acidimeter.
1.3 weighing 0.01g of sample, respectively adding into 100ml of water at 25 ℃ +/-2 ℃, 100ml of ethanol at 25 ℃ +/-2 ℃, 100ml of diethyl ether at 25 ℃ +/-2 ℃, 100ml of dilute sulfuric acid at 25 ℃ +/-2 ℃ and 100ml of 5% sodium hydroxide solution at 225 ℃ +/-2 ℃, strongly shaking for 30s every 5min, and observing the dissolution condition within 30min, wherein the sample is insoluble.
1.4, hydrolyzing the red card skeleton powder, performing paper chromatography separation, developing by using ninhydrin as a color developing agent, and identifying a sample as a red card skeleton by using a Meso-DAP standard product as a control.
1.5 precisely weighing appropriate amounts of ethanol and chloroform, quantitatively diluting with an internal standard solution (taking an appropriate amount of isopropanol, diluting with methanol to obtain a solution containing about 1.0mg of ethanol per 1 ml) to obtain a mixed solution containing about 1.0mg of ethanol and 1.0mg of chloroform per 1ml, precisely weighing 5ml, placing in a headspace bottle, and sealing to obtain a reference solution. A sample (200 mg) was taken and placed in a headspace bottle, and 5ml of the internal standard solution was added precisely, sealed, and shaken to dissolve it, thereby obtaining a sample solution. According to the residual solvent assay, DB-624(30 m.times.0.53 mm. times.2.5 μm) was used as a column, starting at 35 ℃ for 2 minutes, heating at 5 ℃ per minute to 80 ℃, further heating at 25 ℃ per minute to 200 ℃ for 2 minutes, detector temperature 220 ℃, injector temperature 200 ℃, headspace vial equilibration temperature 85 ℃ and equilibration time 20 minutes. And (3) respectively injecting the gas on the liquid after gas-liquid balance of the reference substance solution and the test sample solution into a gas chromatograph, recording the chromatogram, and calculating according to an external standard method by using peak area, wherein the residual quantity of ethanol is not higher than 5000ppm, and the residual quantity of chloroform is not higher than 60 ppm. .
1.6 the detailed operations were carried out in accordance with the microbiological examination protocol QFTL-YsS-03-030-. The result of the test was aseptic growth.
1.7 according to the method in GB/Z21738-2008, and simultaneously according to the characteristics of the red card framework, the detection is carried out by adopting a scanning electron microscope. And (3) placing the framework film of the red card in vacuum, drying to constant, working for 3min by using sputtering current of 4mV, spraying gold on the surface of the sample, and observing the operation of the fiber network structure by using a scanning electron microscope. The detection shows that the fiber diameter and the framework size are less than or equal to 1 micron.
1.8 the skeleton of the red carden consists of components such as arabinogalactan, mycolic acid and the like, wherein the content of the arabinose is 33 percent.
Accurately weighing an appropriate amount of arabinose control substances which are dried at 60 ℃ under reduced pressure for 1h, preparing arabinose into solutions containing 50 mug of arabinose, 60 mug of arabinose, 70 mug of arabinose, 80 mug of arabinose and 90 mug of arabinose per 1ml, accurately weighing 2ml of the solutions, placing the solutions in test tubes with plugs, respectively adding 0.5ml of 2.0% anthrone ethyl acetate solution and 4.0ml of concentrated sulfuric acid under the condition of ice bath cooling, shaking uniformly, preserving the temperature in a water bath at 80 ℃ for 30min, immediately cooling to room temperature by using running water, measuring the optical density at 625nm wavelength by using a spectrophotometry method (using pure water as a blank control instead of a standard solution), wherein the abscissa is the arabinose concentration, and the ordinate is the optical density value, and drawing a standard curve.
Accurately weighing 0.6-1.0 mg of sample into a test tube with a plug by using an analytical balance, and adding 4ml of distilled water for uniformly mixing. Then adding 1.0ml of 2% ethyl acetate anthrone and 8.0ml of concentrated sulfuric acid into ice water bath, shaking up, cooling, developing color in 80 deg.C water bath for 30min, cooling to room temperature with flowing water, measuring optical density at 625nm, and calculating polysaccharide content according to standard curve, wherein the polysaccharide content should not be less than 33%.
It should be understood that the above embodiments are only examples for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications of the invention may be made without departing from the spirit or scope of the invention.
Claims (10)
1. The preparation method of the red card skeleton powder is characterized by comprising the following steps:
step one, inoculating activated Nocardia in a sterilized liquid culture medium, wherein the inoculation amount of 35-75mL of the liquid culture medium is 0.25-0.1mL, and performing shake culture at 24-30 ℃ for more than 24 hours to obtain a bacterial liquid;
the liquid culture medium contains 1 wt% of carbon source and 1 wt% of nitrogen source, the carbon source is glucose, sucrose, starch or mannitol, the nitrogen source is yeast extract, protein gland, urea or a sulfuric acid string, and the pH is 6-8;
step two, taking bacterial liquid, shaking up, centrifuging, discarding supernatant, adding distilled water for dilution, and mixing uniformly to obtain bacterial suspension with the mass concentration of 1.5 g/L;
step three, placing the bacterial suspension into 5-5.5% KOH solution, and carrying out water bath at 100 ℃ for 10-50 min;
or, performing ultrasonic wall breaking on the bacterial suspension, wherein the wall breaking conditions are ultrasonic time 1-15s, interval time 5-15s, cycle number 40-90 times and power 100-;
and step four, extracting the cell wall skeleton, drying and grinding to obtain the red cardskeleton powder.
2. The method for preparing a rbc framework powder according to claim 1, wherein in the first step, the activation process of nocardia is as follows: inoculating Nocardia genus into solid culture medium by streaking, and culturing at 28 deg.C for two days;
the solid medium contains 1 wt% of glucose, 1 wt% of yeast extract and 2 wt% of agar, and has a pH of 7.2.
3. The method for preparing a red card skeleton powder of claim 1, wherein in the first step, the sterilization temperature is 115-118 ℃, and the sterilization time is 20 min.
4. The method for preparing red card skeleton powder of claim 1, wherein in the first step, the rotation speed of the shaking table is 160-320 r/min.
5. A method for preparing a red card skeleton powder according to claim 1, wherein in the first step, the carbon source of the liquid medium is glucose powder, and the nitrogen source is yeast powder; the pH of the liquid medium is 7-8.
6. The method for preparing a red card skeleton powder according to claim 1, wherein the temperature for culturing in the first step is 26 ℃.
7. The method for preparing a red card skeleton powder of claim 1, wherein in the first step, the inoculation amount of 50mL of liquid culture medium is 0.75 mL.
8. The method for preparing a red card skeleton powder according to claim 1, wherein in the second step, the rotation speed of the centrifugation is 4000r/min, and the time is 5 min.
9. The preparation method of the red card skeleton powder according to claim 1, wherein in the third step, the bacterial suspension is placed in a 5% KOH solution and is subjected to water bath at 100 ℃ for 40 min;
in the third step, the wall breaking conditions are ultrasonic time 15s, interval time 15s, cycle number 40 times and power 500W.
10. A red card skeleton powder prepared from the red card skeleton powder of any one of claims 1 to 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010813481.3A CN112063529A (en) | 2020-08-13 | 2020-08-13 | Red card skeleton powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010813481.3A CN112063529A (en) | 2020-08-13 | 2020-08-13 | Red card skeleton powder and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112063529A true CN112063529A (en) | 2020-12-11 |
Family
ID=73661551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010813481.3A Pending CN112063529A (en) | 2020-08-13 | 2020-08-13 | Red card skeleton powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112063529A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094288A (en) * | 1993-04-23 | 1994-11-02 | 福建省微生物研究所 | Utilize nocardia rubra to make the method for cell wall skeleton powder |
CN1443542A (en) * | 2002-03-08 | 2003-09-24 | 沈阳胜宝康生物制药有限公司 | Nocardia rubra actinomycete cell wall skeleton preparation |
CN104099271A (en) * | 2014-07-08 | 2014-10-15 | 谢必峰 | Novel culture method of red Nocard's bacilli |
-
2020
- 2020-08-13 CN CN202010813481.3A patent/CN112063529A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094288A (en) * | 1993-04-23 | 1994-11-02 | 福建省微生物研究所 | Utilize nocardia rubra to make the method for cell wall skeleton powder |
CN1443542A (en) * | 2002-03-08 | 2003-09-24 | 沈阳胜宝康生物制药有限公司 | Nocardia rubra actinomycete cell wall skeleton preparation |
CN104099271A (en) * | 2014-07-08 | 2014-10-15 | 谢必峰 | Novel culture method of red Nocard's bacilli |
Non-Patent Citations (1)
Title |
---|
林清强: ""红色诺卡氏菌发酵条件优化及N-CWS提取工艺的改进研究"", 《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101381694B (en) | Bacteria cellulose producing bacteria and method for preparing bacteria cellulose using above bacterial strain | |
CN108653059A (en) | A kind of probiotics fermention prepares method and the application of the fermentation of seaweed liquid in cosmetics of fermentation of seaweed liquid | |
CN101509025A (en) | Method of preparing bacteria cellulose composite material | |
CN107446825A (en) | One plant of white fungus bacterial strain and its application | |
CN108676736A (en) | The Pichia yeast of one plant of degradable citric acid and its application | |
CN109879985A (en) | A kind of preparation method of medicinal small molecule pectin | |
CN103923865A (en) | Bacteria cellulose producing strain and method for fermenting bacteria cellulose by utilizing same | |
CN107868805A (en) | A kind of longan polysaccharide degraded by lactobacillus-fermented and preparation method thereof | |
CN106282264A (en) | A kind of production method of the sophorolipid with hair regrowth | |
CN108753625A (en) | A kind of production polysaccharide space Hydnum ST21-3 and its application in improving biological immune activity | |
CN117925731B (en) | Galactose yeast-like fungus centella asiatica fermentation product and preparation method and application thereof | |
CN107699558A (en) | Immobilised enzymes, its preparation method and its application in atrazine-contaminated soil is repaired | |
CN108004015A (en) | A kind of Suaeda salsa seed oil supercritical carbon dioxide extraction process | |
CN112063529A (en) | Red card skeleton powder and preparation method thereof | |
CN114028279A (en) | Ganoderma lucidum self-emulsifying grease fermentation liquid, fermentation method and application | |
CN116042422B (en) | Yeast-derived exosome and preparation method and application thereof | |
CN108823266B (en) | A method for preparing chitin by fermentation | |
CN106636252A (en) | Thelephora ganbajun Zang exopolysaccharide, preparation method thereof and application of exopolysaccharide | |
Goebel et al. | A study of pneumococcus autolysis | |
Ishimori et al. | Continuous production of glucose oxidase with Aspergillus sp. under ultrasound waves | |
CN109706203A (en) | A kind of preparation method of high yield hyaluronic acid | |
CN106755184B (en) | Thelephora ganbajun mycelium polysaccharide and its preparation method and application | |
CN102198057B (en) | Oat extract, preparation method thereof and application thereof | |
CN106754562A (en) | A kind of method that the bacterial strain and its fermented tcm discarded object of high yield bacterial polysaccharides prepare polysaccharide | |
CN108676728B (en) | Polysaccharide-producing space coralloid hericium ST21-2 and application thereof in improving biological oxidation resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201211 |
|
RJ01 | Rejection of invention patent application after publication |